BIOX — BIOCERES CROP SOLUTIONS CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BIOCERES CROP SOLUTIONS CORP (BIOX)
BIOCERES CROP SOLUTIONS CORP (BIOX) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Paul Tudor Jones (Tudor Investment Corp), valued at $288,855. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BIOX
How many top investors track BIOX
A small number of top investors own this.
BIOX Ownership Composition
How BIOCERES CROP SOLUTIONS CORP is held across tracked investor types, based on reported 13F positions.
- Other94.1%
- Hedge Funds5.9%
Tracked investors reporting BIOX
- Paul Tudor JonesDec 31, 2025Tudor Investment CorpShares220.5KValue$288.9K% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares11.9KValue$5.3K% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares14KValue$18.4K% Portfolio0.00%
Recent activity
- $288.9KFeb 17, 2026
- New$18.4KFeb 17, 2026
- New$5.3KMay 15, 2026
- New$235.5KNov 14, 2025
Frequently asked questions
- How many institutional investors hold BIOX?
- 3 tracked institutional investors disclosed a position in BIOX (BIOCERES CROP SOLUTIONS CORP) in their most recent 13F filing.
- Who is the largest institutional holder of BIOX?
- Paul Tudor Jones, Tudor Investment Corp, holds the largest disclosed position in BIOX, valued at $288,855.
- Did institutional ownership of BIOX increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited BIOX.
- Where does this BIOX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.